Stocks and Investing
Stocks and Investing
Wed, August 10, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Gary Nachman Maintained (BHC) at Hold with Decreased Target to $8 on, Aug 10th, 2022
Gary Nachman of BMO Capital, Maintained "Bausch Health Companies Inc." (BHC) at Hold with Decreased Target from $15 to $8 on, Aug 10th, 2022.
Gary has made no other calls on BHC in the last 4 months.
There are 2 other peers that have a rating on BHC. Out of the 2 peers that are also analyzing BHC, all agree with Gary's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Chris Schott of "JP Morgan" Downgraded from Buy to Hold on, Friday, July 29th, 2022
- Gregory Fraser of "Truist Securities" Downgraded from Strong Buy to Hold on, Friday, July 29th, 2022
Contributing Sources